Paradigm Biocapital Advisors LP Olema Pharmaceuticals, Inc. Transaction History
Paradigm Biocapital Advisors LP
- $2.77 Billion
- Q3 2024
A detailed history of Paradigm Biocapital Advisors LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 5,503,600 shares of OLMA stock, worth $34.7 Million. This represents 2.37% of its overall portfolio holdings.
Number of Shares
5,503,600
Previous 7,903,600
30.37%
Holding current value
$34.7 Million
Previous $85.5 Million
23.16%
% of portfolio
2.37%
Previous 3.46%
Shares
5 transactions
Others Institutions Holding OLMA
# of Institutions
136Shares Held
58.7MCall Options Held
141KPut Options Held
23.1K-
Bvf Inc San Francisco, CA9.14MShares$57.6 Million3.47% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$25.2 Million1.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$25.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$23.2 Million0.12% of portfolio
-
Logos Global Management LP San Francisco, CA3.21MShares$20.2 Million5.07% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $255M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...